Factor V(Leiden) and thrombophilia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 4, 1997, Pages 620-627

  Kalafatis, Michael ^a   Mann, Kenneth G ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

activated protein C; activated protein C resistance; factor V(Leiden); thrombophilia; venous thrombosis

Indexed keywords

ACTIVATED PROTEIN C; ARGININE; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8; GLUTAMINE; PROTEIN S; THROMBOPLASTIN; BLOOD CLOTTING FACTOR 5 LEIDEN; PROTEIN C;

AMINO ACID SUBSTITUTION; AUTOSOME; BLOOD CLOTTING FACTOR 5 DEFICIENCY; FIBRINOLYSIS; GENE MUTATION; HETEROZYGOTE; HUMAN; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; THROMBOPHILIA; VEIN THROMBOSIS; GENETICS; PHYSIOLOGY; POINT MUTATION; STRUCTURE ACTIVITY RELATION; THROMBOSIS;

FACTOR V; FACTOR VA; FACTOR VIII; FIBRINOLYSIS; HUMANS; POINT MUTATION; PROTEIN C; STRUCTURE-ACTIVITY RELATIONSHIP; THROMBOSIS;

EID: 0030615327     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.4.620     Document Type: Review

References (13)

1. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood. 1993;81:734-744.
2. Lawson JH, Butenas S, Mann KG. The evaluation of complex-dependent alterations in human factor VIIa. J Biol Chem. 1992;267: 4834-4843.
3. Lawson JH, Butenas S, Ribarik N, Mann KG. Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. J Biol Chem. 1993;268:767-770.
4. Mann KG, Nesheim ME, Church WR, Haley PE, Krishnaswamy S. Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood. 1990;76:1-16.
5. Esmon CT. The regulation of natural anticoagulant pathways. Science. 1987;235:1348-1352.
6. Lollar P, Parker CG. pH-dependent denaturation of thrombin-activated porcine factor VIII. J Biol Chem. 1990;265:1688-1692.
7. Fay PJ, Haidaris PJ, Smudzin TM. Human factor VIIIa subunit structure. J Biol Chem. 1991;266:8957-8962.
8. Lu D, Kalafatis M, Mann KG, Long GL. Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V. Blood. 1996;87:4708-4717.
9. van 't Veer C, Golden NJ, Kalafatis M, Mann KG. Inhibitory mechanism of the protein C pathway on tissue factor induced thrombin generation: synergistic effect in combination with tissue factor pathway inhibitor. J Biol Chem. 1997;272:7983-7994.
10. Kalafatis M, Mann KG. Role of the membrane in the inactivation of factor Va by activated protein C. J Biol Chem. 1993;268:27246-27257.
11. Kalafatis M, Rand MD, Mann KG. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem. 1994;269:31869-31880.
12. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anti-coagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA. 1993;90:1004-1008.
13. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-67.